Coral Laboratories Limited (CORALAB.BO)
INR 747.6
(-3.64%)
INR 747.6
(-3.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 230.38 Million | 126.65 Million | 60.83 Million | 9.3 Million | -38.62 Million | -8.82 Million |
| Net Income | 157.89 Million | 81.88 Million | 108.96 Million | 175.93 Million | 91.17 Million | 155.06 Million |
| Depreciation & Amortization | 19.75 Million | 21.8 Million | 19.9 Million | 19.83 Million | 20.06 Million | 19.02 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 54.25 Million | 60.63 Million | -4.36 Million | -130.81 Million | -133.9 Million | -125.93 Million |
| Other non-cash items | 21.96 Million | -37.66 Million | -63.66 Million | -55.64 Million | -15.96 Million | -56.98 Million |
| Investing Cash Flow | -21.69 Million | -26.14 Million | -60.51 Million | -681 Thousand | -15.51 Million | 32.32 Million |
| Investments in PPE | -9.91 Million | -19.45 Million | -55.48 Million | -13.6 Million | -13.79 Million | -28.16 Million |
| Acquisitions | - | 20 Million | - | - | 449 Thousand | - |
| Investment purchases | - | -20 Million | -20.32 Million | - | - | - |
| Sales/Maturities of investments | 1.81 Million | 2.68 Million | - | - | - | 50.04 Million |
| Other Investing Activities | -13.6 Million | -9.38 Million | 15.29 Million | 12.92 Million | -2.16 Million | 10.44 Million |
| Financing Cash Flow | 68 Thousand | -64.26 Million | 1.49 Million | 3.5 Million | 35.57 Million | -11.82 Million |
| Debt repayment | -68 Thousand | -60.87 Million | -2.9 Million | -3.41 Million | -44.76 Million | -2.99 Million |
| Dividends payments | - | - | - | - | -8.61 Million | -8.6 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2000.00 | -3.38 Million | 4.39 Million | 6.91 Million | 88.95 Million | -230 Thousand |
| Accounts receivables | -47.72 Million | 146.93 Million | 10.45 Million | -47.51 Million | -40.84 Million | 12.88 Million |
| Accounts payables | 90.28 Million | -51.13 Million | -55.69 Million | 6.42 Million | 14.37 Million | -1.18 Million |
| Inventory | -26.52 Million | 58.58 Million | 33.12 Million | -23.76 Million | -31.26 Million | 13.77 Million |
| Other working capital | 38.22 Million | -93.75 Million | 7.75 Million | -65.96 Million | -76.17 Million | -151.4 Million |
| Cash at beginning of period | 405.58 Million | 25.06 Million | 23.24 Million | 11.11 Million | 29.68 Million | 18.01 Million |
| Cash at end of period | 612.82 Million | 61.3 Million | 25.06 Million | 23.24 Million | 11.11 Million | 29.68 Million |
| Capital Expenditure | -9.91 Million | -19.45 Million | -55.48 Million | -13.6 Million | -13.79 Million | -28.16 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 207.24 Million | 36.24 Million | 1.81 Million | 12.12 Million | -18.56 Million | 11.66 Million |
| Free Cash Flow | 220.47 Million | 107.19 Million | 5.35 Million | -4.29 Million | -52.42 Million | -36.99 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 157.89 Million | 21.56 Million | 60.03 Million | 18.41 Million | 81.88 Million | -8.92 Million |
| Depreciation & Amortization | 19.75 Million | 4.91 Million | 4.36 Million | 5.45 Million | 21.8 Million | 6.79 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 54.25 Million | - | - | - | 60.63 Million | - |
| Other non-cash items | 21.96 Million | -16.65 Million | -4.36 Million | -5.45 Million | -37.66 Million | -6.79 Million |
| Investing Cash Flow | -21.69 Million | - | - | - | -26.14 Million | - |
| Investments in PPE | -9.91 Million | - | - | - | -19.45 Million | - |
| Acquisitions | - | - | - | - | 20 Million | - |
| Investment purchases | - | - | - | - | -20 Million | - |
| Sales/Maturities of investments | 1.81 Million | - | - | - | 2.68 Million | - |
| Other Investing Activities | -13.6 Million | - | - | - | -9.38 Million | - |
| Financing Cash Flow | 68 Thousand | - | - | - | -64.26 Million | - |
| Debt repayment | -68 Thousand | - | - | - | -60.87 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -3.38 Million | - |
| Accounts receivables | -47.72 Million | - | - | - | 146.93 Million | - |
| Accounts payables | 90.28 Million | - | - | - | -51.13 Million | - |
| Inventory | -26.52 Million | - | - | - | 58.58 Million | - |
| Other working capital | 38.22 Million | - | - | - | -93.75 Million | - |
| Cash at beginning of period | 405.58 Million | 544.53 Million | 484.49 Million | 405.58 Million | 25.06 Million | 414.5 Million |
| Cash at end of period | 612.82 Million | 554.35 Million | 544.53 Million | 18.41 Million | 61.3 Million | 405.58 Million |
| Capital Expenditure | -9.91 Million | - | - | - | -19.45 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 207.24 Million | 9.82 Million | 60.03 Million | -387.16 Million | 36.24 Million | -8.92 Million |
| Free Cash Flow | 220.47 Million | 9.82 Million | 60.03 Million | 18.41 Million | 107.19 Million | -8.92 Million |
PENINLAND
300805
RNDOF
MEDICO
MDRNSTL
GALXBRG